作者：
Tacconelli, Evelina [1]
;
Carrara, Elena [2]
;
Savoldi, Alessia [3]
;
Harbarth, Stephan [4]
;
Mendelson, Marc [5]
;
Monnet, Dominique L. [6]
;
Pulcini, Celine [7]
;
Kahlmeter, Gunnar [8]
;
Kluytmans, Jan [9]
;
Carmeli, Yehuda [10]
;
Ouellette, Marc [11]
;
Outterson, Kevin [12]
;
Patel, Jean [13]
;
Cavaleri, Marco [14]
;
Cox, Edward M. [15]
;
Houchens, Chris R. [16]
;
Grayson, M. Lindsay [17]
;
Hansen, Paul [18]
;
Singh, Nalini [19]
;
Theuretzbacher, Ursula ;
Magrini, Nicola
作者单位：
Laval Univ, Quebec City, PQ, Canada
[1]
Boston Univ, Combating Antibiot Resistant Bacteria Biopharmace, Boston, MA USA
[2]
WHO, Geneva Univ Hosp, Collaborating Ctr Patient Safety, Geneva, Switzerland
[3]
Biomed Adv Res & Dev Author, Antibacterials Program, Washington, DC USA
[4]
Univ Med Ctr, Utrecht, Netherlands
[5]
European Med Agcy, London, England
[6]
Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia
[7]
WHO, Essential Med & Hlth Prod, Geneva, Switzerland
[8]
Univ Cape Town, Groote Schuur Hosp, Cape Town, South Africa
[9]
George Washington Univ, Childrens Natl Hlth Syst, Washington, DC USA
[10]
European Ctr Dis Prevent & Control, Stockholm, Sweden
[11]
Cent Hosp Vaxjo, Vaxjo, Sweden
[12]
Ctr Dis Control & Prevent, Atlanta, GA USA
[13]
US FDA, Washington, DC 20204 USA
[14]
Ctr Antiinfect Agents, Vienna, Austria
[15]
Univ Tubingen Hosp, German Ctr Infect Res, Tubingen, Germany
[16]
Tel Aviv Univ, Lab Microbiol & Infect Control, Tel Aviv, Israel
[17]
Univ Otago, Dept Infect Dis & Microbiol, Dunedin, New Zealand
[18]
Lorraine Univ, Nancy Univ Hosp, EA APEMAC 4360, Nancy, France
[19]
发布时间
2018-05-10
换一批
